Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Adipose-Derived SVF for Knee Osteoarthritis
NCT02846675Phase 2Completed
- Sponsor
- Shanghai East Hospital
- Start
- Nov 2014
- Primary completion
- Jul 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous adipose-derived stromal vascular fraction in osteoarthritis (OA) (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 6 months. Started Nov 2014; status: completed.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02846675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02846675.